Abstract:Objective: This study aimed to investigate the clinical implications of fasting serum insulin (FINS) levels in subjects with type 2 diabetes who were receiving insulin therapy. Methods: A total of 1,553 subjects with type 2 diabetes [774 subjects who had never received insulin treatment (N-INS) and 779 subjects who were receiving insulin therapy (constant insulin treatment, C-INS)] admitted to the Department of Endocrinology and Metabolism of Peking University People's Hospital were enrolled in this study. Their FINS levels were measured and those with hyperinsulinemia were identified. The underlying mechanisms of hyperinsulinemia were revealed by measuring insulin antibodies (IAs) and analyzing changes in FINS levels before and after polyethylene glycol (PEG) precipitation. In addition, the clinical characteristics of patients with different types of hyperinsulinemia were compared. Results: Higher FINS levels and a higher incidence (43.8%, 341/779) of hyperinsulinemia (FINS > 15 mu IU/mL) were observed in subjects with C-INS than in subjects with N-INS. Among subjects with C-INS and hyperinsulinemia, 66.9% (228/341) were IAs positive, and the incidence of IAs was found to be positively associated with FINS level. By performing PEG precipitation, we found that all subjects without IAs (i.e., those with real hyperinsulinemia) and 31.1% of subjects (71/228) with IAs (i.e., those with both real and IAs-related hyperinsulinemia) still had hyperinsulinemia after PEG precipitation, whereas FINS levels in the other 68.9% of subjects (157/228) with IAs were normal (IAs-related hyperinsulinemia) after PEG precipitation. Comparisons between the groups showed that subjects with real hyperinsulinemia showed more obvious insulin resistance characteristics, including higher lipid levels, BMIs, and homoeostasis model assessment2-estimated insulin resistance (HOMA2-IR) index, and were more likely to have hypertension, obesity, and metabolic syndromes (p < 0.05). However, the risk of hypoglycemia and glucose variability increased significantly in subjects with IAs compared with those without IAs. A cutoff of FINS to serum C-peptide ratio (>= 9.3 mu IU/ng) could be used to screen IAs in clinical practice with 83.3% sensitivity and 70% specificity. Conclusions: It is necessary to measure FINS in subjects with C-INS to distinguish between types of hyperinsulinemia, which should help to tailor treatment regimens.

Relationship Between Basal Insulin Secretion and Free Fatty Acid Levels in Normal Glucose Regulating Subjects

Relationship Between Early–phase Insulin Secretion and Blood Glucose Variability in Subject with Normal Glucose Regulation

The Clinical Implications of Fasting Serum Insulin Levels in Patients with Insulin-Treated Type 2 Diabetes: a Cross-Sectional Survey

[The Correlation Between Serum Uric Acid Level and Early-Phase Insulin Secretion in Subjects with Normal Glucose Regulation].

Serum Liver-Type Fatty Acid Binding Protein Level and Related Factors in Obese Young Adults

Insulin Resistance,early Phase Insulin Secretion and Serum Free Fatty Acid Levels in Impaired Glucose Regulation Subjects

STUDY ON OBESITY RELATED FACTORS: FFA, LEPTIN AND ADIPONECTIN IN SUBJECTS WITH VARYING GLUCOSE TOLERANCE

Relationship between serum FGF -19, FGF -21 levels and insulin resistance in women with gestational diabetes mellitus

Fasting serum free fatty acid, insulin sensitivity index and serum lipid levels in individuals with different body mass index and glucose tolerance]

Association between serum somatostatin levels and glucose-lipid metabolism in the Jino ethnic minority and Han Chinese population

Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China.

Study of the insulin sensitivity and β-cell function in cases with postprandial and fasting hyperglycemia

Generating a Reference Interval for Fasting Serum Insulin in Healthy Nondiabetic Adult Chinese Men.

Association of Β‐cell Function and Insulin Sensitivity with Fasting and 2‐h Plasma Glucose in a Large Chinese Population

Serum Adiponectin Concentration in Relation to Body Fat Distribution and Tissue Insulin Sensitivity in the Glucose Clamp Study

Relationship of fasting plasma glucose with β-cell function and insulin sensitivity

Non-linear Associations of Body Mass Index with Impaired Fasting Glucose, Β-Cell Dysfunction, and Insulin Resistance in Nondiabetic Chinese Individuals: a Cross-Sectional Study.

Fasting Serum Glucagon-Like Peptide-1 Concentrations In Obese Patients With Acanthosis Nigricans: A Pilot Study

Correlation Between Blood Pressure and Insulin Resistance and Secretion in Population with Normal Glucose Tolerance.

Serum Fibroblast Growth Factor 21 is Associated with Adverse Lipid Profiles and Gamma-Glutamyltransferase but Not Insulin Sensitivity in Chinese Subjects

Associations Between Serum Free Fatty Acid Levels and Incident Diabetes in a 3-Year Cohort Study.